{"product_id":"retatrutide-20mg","title":"Retatrutide 20mg","description":"\u003ch1 data-section-id=\"lafn1k\" data-start=\"111\" data-end=\"130\" class=\"PDq2pG_selectionAnchorContainer\"\u003eRetatrutide Facts\u003cspan aria-hidden=\"true\" class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h1\u003e\n\u003ch2 data-section-id=\"1c003fr\" data-start=\"132\" data-end=\"155\"\u003eWhat is Retatrutide?\u003c\/h2\u003e\n\u003cp data-start=\"157\" data-end=\"347\"\u003eRetatrutide (LY3437943) is an \u003cstrong data-start=\"187\" data-end=\"224\"\u003einvestigational synthetic peptide\u003c\/strong\u003e developed by Eli Lilly. It is the first advanced clinical-stage \u003cstrong data-start=\"289\" data-end=\"324\"\u003etriple hormone receptor agonist\u003c\/strong\u003e, designed to activate:\u003c\/p\u003e\n\u003cul data-start=\"349\" data-end=\"488\"\u003e\n\u003cli data-section-id=\"gqv8h8\" data-start=\"349\" data-end=\"396\"\u003e\u003cstrong data-start=\"351\" data-end=\"396\"\u003eGLP-1 (Glucagon-Like Peptide-1) receptors\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli data-section-id=\"1q2we81\" data-start=\"397\" data-end=\"463\"\u003e\u003cstrong data-start=\"399\" data-end=\"463\"\u003eGIP (Glucose-Dependent Insulinotropic Polypeptide) receptors\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli data-section-id=\"7xvxxl\" data-start=\"464\" data-end=\"488\"\u003e\u003cstrong data-start=\"466\" data-end=\"488\"\u003eGlucagon receptors\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"490\" data-end=\"833\"\u003eBecause it simultaneously targets all three pathways, retatrutide is commonly referred to as a \u003cstrong data-start=\"585\" data-end=\"603\"\u003etriple agonist\u003c\/strong\u003e. It is currently being investigated as a once-weekly subcutaneous injection for obesity, type 2 diabetes, and several obesity-related conditions. It has \u003cstrong data-start=\"757\" data-end=\"794\"\u003enot been approved by the U.S. FDA\u003c\/strong\u003e. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"835\" data-end=\"838\"\u003e\n\u003ch2 data-section-id=\"15zexxv\" data-start=\"840\" data-end=\"860\"\u003eBasic Information\u003c\/h2\u003e\n\u003cul data-start=\"862\" data-end=\"1305\"\u003e\n\u003cli data-section-id=\"gik85j\" data-start=\"862\" data-end=\"901\"\u003e\n\u003cstrong data-start=\"864\" data-end=\"883\"\u003eCompound Class:\u003c\/strong\u003e Synthetic peptide\u003c\/li\u003e\n\u003cli data-section-id=\"2f1wv5\" data-start=\"902\" data-end=\"976\"\u003e\n\u003cstrong data-start=\"904\" data-end=\"923\"\u003eAdministration:\u003c\/strong\u003e Once-weekly subcutaneous injection (investigational)\u003c\/li\u003e\n\u003cli data-section-id=\"1bqc2rx\" data-start=\"977\" data-end=\"1006\"\u003e\n\u003cstrong data-start=\"979\" data-end=\"1003\"\u003eNaturally Occurring:\u003c\/strong\u003e No\u003c\/li\u003e\n\u003cli data-section-id=\"wx3nu8\" data-start=\"1007\" data-end=\"1087\"\u003e\n\u003cstrong data-start=\"1009\" data-end=\"1029\"\u003ePrimary Targets:\u003c\/strong\u003e\n\u003cul data-start=\"1032\" data-end=\"1087\"\u003e\n\u003cli data-section-id=\"1i88umf\" data-start=\"1032\" data-end=\"1048\"\u003eGLP-1 receptor\u003c\/li\u003e\n\u003cli data-section-id=\"1dezq4e\" data-start=\"1051\" data-end=\"1065\"\u003eGIP receptor\u003c\/li\u003e\n\u003cli data-section-id=\"atrpoa\" data-start=\"1068\" data-end=\"1087\"\u003eGlucagon receptor\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli data-section-id=\"i4l77w\" data-start=\"1088\" data-end=\"1305\"\u003e\n\u003cstrong data-start=\"1090\" data-end=\"1117\"\u003ePrimary Research Areas:\u003c\/strong\u003e\n\u003cul data-start=\"1120\" data-end=\"1305\"\u003e\n\u003cli data-section-id=\"1sdi1jr\" data-start=\"1120\" data-end=\"1129\"\u003eObesity\u003c\/li\u003e\n\u003cli data-section-id=\"1k4eot7\" data-start=\"1132\" data-end=\"1151\"\u003eWeight management\u003c\/li\u003e\n\u003cli data-section-id=\"1ubisqz\" data-start=\"1154\" data-end=\"1171\"\u003eType 2 diabetes\u003c\/li\u003e\n\u003cli data-section-id=\"cq06k2\" data-start=\"1174\" data-end=\"1197\"\u003eMetabolic dysfunction\u003c\/li\u003e\n\u003cli data-section-id=\"h8y7v8\" data-start=\"1200\" data-end=\"1221\"\u003eCardiovascular risk\u003c\/li\u003e\n\u003cli data-section-id=\"nkco74\" data-start=\"1224\" data-end=\"1239\"\u003eLiver disease\u003c\/li\u003e\n\u003cli data-section-id=\"1dw9lsx\" data-start=\"1242\" data-end=\"1305\"\u003eObstructive sleep apnea \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"1307\" data-end=\"1310\"\u003e\n\u003ch2 data-section-id=\"uz8gfd\" data-start=\"1312\" data-end=\"1334\"\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp data-start=\"1336\" data-end=\"1441\"\u003eRetatrutide combines the activity of three naturally occurring metabolic hormones into a single molecule.\u003c\/p\u003e\n\u003cp data-start=\"1443\" data-end=\"1520\"\u003eResearchers believe each receptor contributes distinct physiological effects:\u003c\/p\u003e\n\u003ch3 data-section-id=\"1kaoykd\" data-start=\"1522\" data-end=\"1551\"\u003eGLP-1 Receptor Activation\u003c\/h3\u003e\n\u003cp data-start=\"1553\" data-end=\"1602\"\u003eResearch has shown GLP-1 receptor activation may:\u003c\/p\u003e\n\u003cul data-start=\"1604\" data-end=\"1693\"\u003e\n\u003cli data-section-id=\"hk6l57\" data-start=\"1604\" data-end=\"1622\"\u003eIncrease satiety\u003c\/li\u003e\n\u003cli data-section-id=\"1w4lplv\" data-start=\"1623\" data-end=\"1646\"\u003eSlow gastric emptying\u003c\/li\u003e\n\u003cli data-section-id=\"2gp1nk\" data-start=\"1647\" data-end=\"1664\"\u003eReduce appetite\u003c\/li\u003e\n\u003cli data-section-id=\"fx5pwi\" data-start=\"1665\" data-end=\"1693\"\u003eImprove glucose regulation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"1695\" data-end=\"1698\"\u003e\n\u003ch3 data-section-id=\"1k06ijo\" data-start=\"1700\" data-end=\"1727\"\u003eGIP Receptor Activation\u003c\/h3\u003e\n\u003cp data-start=\"1729\" data-end=\"1804\"\u003eGIP receptor activation has been investigated for its potential effects on:\u003c\/p\u003e\n\u003cul data-start=\"1806\" data-end=\"1888\"\u003e\n\u003cli data-section-id=\"919s7b\" data-start=\"1806\" data-end=\"1826\"\u003eGlucose metabolism\u003c\/li\u003e\n\u003cli data-section-id=\"1e5xyd8\" data-start=\"1827\" data-end=\"1846\"\u003eInsulin secretion\u003c\/li\u003e\n\u003cli data-section-id=\"1owiavg\" data-start=\"1847\" data-end=\"1863\"\u003eEnergy balance\u003c\/li\u003e\n\u003cli data-section-id=\"j8jxsp\" data-start=\"1864\" data-end=\"1888\"\u003eAdipose tissue biology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"1890\" data-end=\"1893\"\u003e\n\u003ch3 data-section-id=\"1w03y8w\" data-start=\"1895\" data-end=\"1927\"\u003eGlucagon Receptor Activation\u003c\/h3\u003e\n\u003cp data-start=\"1929\" data-end=\"2018\"\u003eUnlike currently approved GLP-1 therapies, retatrutide also activates glucagon receptors.\u003c\/p\u003e\n\u003cp data-start=\"2020\" data-end=\"2085\"\u003eResearchers believe glucagon receptor activity may contribute to:\u003c\/p\u003e\n\u003cul data-start=\"2087\" data-end=\"2193\"\u003e\n\u003cli data-section-id=\"m8ezfb\" data-start=\"2087\" data-end=\"2117\"\u003eIncreased energy expenditure\u003c\/li\u003e\n\u003cli data-section-id=\"1906suq\" data-start=\"2118\" data-end=\"2142\"\u003eEnhanced fat oxidation\u003c\/li\u003e\n\u003cli data-section-id=\"g0bp7l\" data-start=\"2143\" data-end=\"2158\"\u003eThermogenesis\u003c\/li\u003e\n\u003cli data-section-id=\"v9d6m8\" data-start=\"2159\" data-end=\"2193\"\u003eReduced hepatic fat accumulation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2195\" data-end=\"2345\"\u003eThe combination of these three pathways is believed to underlie retatrutide's investigational metabolic effects. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"2347\" data-end=\"2350\"\u003e\n\u003ch2 data-section-id=\"zfwynl\" data-start=\"2352\" data-end=\"2372\"\u003eAreas of Research\u003c\/h2\u003e\n\u003ch3 data-section-id=\"iv2ux\" data-start=\"2374\" data-end=\"2385\"\u003eObesity\u003c\/h3\u003e\n\u003cp data-start=\"2387\" data-end=\"2458\"\u003eRetatrutide is primarily being investigated as a treatment for obesity.\u003c\/p\u003e\n\u003cp data-start=\"2460\" data-end=\"2509\"\u003eLarge Phase 2 and Phase 3 studies have evaluated:\u003c\/p\u003e\n\u003cul data-start=\"2511\" data-end=\"2612\"\u003e\n\u003cli data-section-id=\"1oei0xv\" data-start=\"2511\" data-end=\"2540\"\u003eTotal body weight reduction\u003c\/li\u003e\n\u003cli data-section-id=\"16x5ctr\" data-start=\"2541\" data-end=\"2562\"\u003eWaist circumference\u003c\/li\u003e\n\u003cli data-section-id=\"gig8dc\" data-start=\"2563\" data-end=\"2581\"\u003eBody composition\u003c\/li\u003e\n\u003cli data-section-id=\"1v0glw1\" data-start=\"2582\" data-end=\"2612\"\u003eCardiometabolic risk factors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"2614\" data-end=\"2827\"\u003ePhase 3 studies have reported average weight reductions approaching 28% at the highest investigational dose over approximately 80 weeks, although regulatory review is ongoing. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"2829\" data-end=\"2832\"\u003e\n\u003ch3 data-section-id=\"1rrga2t\" data-start=\"2834\" data-end=\"2853\"\u003eType 2 Diabetes\u003c\/h3\u003e\n\u003cp data-start=\"2855\" data-end=\"2896\"\u003eResearchers are studying retatrutide for:\u003c\/p\u003e\n\u003cul data-start=\"2898\" data-end=\"3004\"\u003e\n\u003cli data-section-id=\"1vo1pzw\" data-start=\"2898\" data-end=\"2916\"\u003eGlycemic control\u003c\/li\u003e\n\u003cli data-section-id=\"v67xjc\" data-start=\"2917\" data-end=\"2934\"\u003eHbA1c reduction\u003c\/li\u003e\n\u003cli data-section-id=\"14h546n\" data-start=\"2935\" data-end=\"2956\"\u003eInsulin sensitivity\u003c\/li\u003e\n\u003cli data-section-id=\"yk9btz\" data-start=\"2957\" data-end=\"3004\"\u003eWeight reduction in individuals with diabetes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3006\" data-end=\"3172\"\u003ePhase 3 clinical trials have reported improvements in both blood glucose control and body weight in adults with type 2 diabetes. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"3174\" data-end=\"3177\"\u003e\n\u003ch3 data-section-id=\"1rdv5vy\" data-start=\"3179\" data-end=\"3196\"\u003eLiver Disease\u003c\/h3\u003e\n\u003cp data-start=\"3198\" data-end=\"3252\"\u003eRetatrutide is being investigated in individuals with:\u003c\/p\u003e\n\u003cul data-start=\"3254\" data-end=\"3352\"\u003e\n\u003cli data-section-id=\"h0ulqv\" data-start=\"3254\" data-end=\"3320\"\u003eMetabolic dysfunction-associated steatotic liver disease (MASLD)\u003c\/li\u003e\n\u003cli data-section-id=\"he49o9\" data-start=\"3321\" data-end=\"3352\"\u003eExcess liver fat accumulation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"3354\" data-end=\"3502\"\u003eResearchers are evaluating whether improvements in weight and metabolism translate into improved liver health. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"3504\" data-end=\"3507\"\u003e\n\u003ch3 data-section-id=\"puxk9h\" data-start=\"3509\" data-end=\"3535\"\u003eCardiovascular Disease\u003c\/h3\u003e\n\u003cp data-start=\"3537\" data-end=\"3747\"\u003eClinical trials are evaluating retatrutide in people with established cardiovascular disease to determine its effects on cardiovascular outcomes alongside weight reduction. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"3749\" data-end=\"3752\"\u003e\n\u003ch3 data-section-id=\"o05hv6\" data-start=\"3754\" data-end=\"3781\"\u003eObstructive Sleep Apnea\u003c\/h3\u003e\n\u003cp data-start=\"3783\" data-end=\"3981\"\u003eBecause obesity contributes to obstructive sleep apnea (OSA), retatrutide is also being studied for its potential impact on OSA severity in adults with obesity. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"3983\" data-end=\"3986\"\u003e\n\u003ch2 data-section-id=\"1uqv7tv\" data-start=\"3988\" data-end=\"4005\"\u003eHuman Research\u003c\/h2\u003e\n\u003cp data-start=\"4007\" data-end=\"4086\"\u003eRetatrutide has been evaluated in multiple Phase 2 and Phase 3 clinical trials.\u003c\/p\u003e\n\u003cp data-start=\"4088\" data-end=\"4114\"\u003eResearch has demonstrated:\u003c\/p\u003e\n\u003cul data-start=\"4116\" data-end=\"4236\"\u003e\n\u003cli data-section-id=\"x7lg5o\" data-start=\"4116\" data-end=\"4151\"\u003eSignificant body weight reduction\u003c\/li\u003e\n\u003cli data-section-id=\"o9qyje\" data-start=\"4152\" data-end=\"4183\"\u003eImprovements in blood glucose\u003c\/li\u003e\n\u003cli data-section-id=\"qlmv4v\" data-start=\"4184\" data-end=\"4236\"\u003eImprovements in several cardiometabolic biomarkers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"4238\" data-end=\"4439\"\u003eThe medication remains investigational, and additional studies are ongoing to better characterize its long-term safety and efficacy across multiple disease states. \u003cbr\u003e\u003cbr\u003e\u003cstrong data-start=\"5951\" data-end=\"5973\"\u003eResearch Use Only:\u003c\/strong\u003e This product is intended exclusively for laboratory and scientific research by qualified professionals. It is \u003cstrong data-start=\"6084\" data-end=\"6128\"\u003enot intended for human or veterinary use\u003c\/strong\u003e, diagnosis, treatment, cure, or prevention of any disease. This product has \u003cstrong data-start=\"6205\" data-end=\"6286\"\u003enot been evaluated or approved by the U.S. Food and Drug Administration (FDA)\u003c\/strong\u003e. Handle and store in accordance with applicable laboratory safety procedures.\u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42991964618823,"sku":null,"price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0692\/9104\/9031\/files\/Retatrutide20mg.png?v=1784749277","url":"https:\/\/dnyay.us\/products\/retatrutide-20mg","provider":"DNYAY","version":"1.0","type":"link"}